BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33179192)

  • 1. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.
    Yamaguchi T; Takashima A; Nagashima K; Terashima M; Aizawa M; Ohashi M; Tanaka R; Yamada T; Kinoshita T; Matsushita H; Ishiyama K; Hosoda K; Yuasa Y; Haruta S; Kakihara N; Nishikawa K; Yunome G; Satoh T; Fukagawa T; Katai H; Boku N
    Gastric Cancer; 2021 May; 24(3):701-709. PubMed ID: 33179192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
    Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
    Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
    Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
    Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy with S-1 followed by docetaxel for gastric cancer and CY1P0 peritoneal metastasis after relatively curative surgery.
    Kanazawa Y; Kato S; Fujita I; Onodera H; Uchida E
    J Nippon Med Sch; 2013; 80(5):378-83. PubMed ID: 24189356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
    Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
    Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytology.
    Li B; Miao R; Shan F; Li S; Jia Y; Xue K; Li Z; Ying X; Pang F; Zhang Y; Ji J; Li Z
    World J Surg Oncol; 2023 Jul; 21(1):204. PubMed ID: 37434202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
    Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
    Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.
    Kano K; Aoyama T; Maezawa Y; Nakajima T; Ikeda K; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
    Int J Clin Oncol; 2017 Oct; 22(5):887-896. PubMed ID: 28456896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macroscopic type is implicated in the prognostic impact of initial chemotherapy on peritoneal lavage cytology-positive gastric cancer with no other noncurative factors.
    Kano Y; Ichikawa H; Aizawa M; Muneoka Y; Usui K; Hanyu T; Ishikawa T; Yabusaki H; Kobayashi K; Kuwabara S; Makino S; Kawachi Y; Miura K; Tajima Y; Shimada Y; Sakata J; Wakai T
    Int J Clin Oncol; 2024 Jun; 29(6):790-800. PubMed ID: 38512543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy.
    Yasufuku I; Nunobe S; Ida S; Kumagai K; Ohashi M; Hiki N; Sano T
    Gastric Cancer; 2020 Mar; 23(2):319-327. PubMed ID: 31350702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients.
    Masuda T; Kuramoto M; Shimada S; Ikeshima S; Yamamoto K; Nakamura K; Yoshimatsu S; Urata M; Baba H
    Int J Clin Oncol; 2016 Apr; 21(2):289-294. PubMed ID: 26296529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
    Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer.
    Satoh S; Okabe H; Teramukai S; Hasegawa S; Ozaki N; Ueda S; Tsuji A; Sakabayashi S; Fukushima M; Sakai Y
    Gastric Cancer; 2012 Jan; 15(1):61-9. PubMed ID: 21667134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
    Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
    Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of initial treatment for peritoneal lavage cytology-positive gastric cancer: outcomes according to treatment strategy.
    Yago A; Haruta S; Ueno M; Ogawa Y; Shimoyama H; Ohkura Y; Udagawa H
    World J Surg Oncol; 2022 Feb; 20(1):35. PubMed ID: 35168610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis.
    Hao Y; Liu Y; Ishibashi H; Wakama S; Nishino E; Yonemura Y
    Eur J Surg Oncol; 2019 Aug; 45(8):1493-1497. PubMed ID: 30948161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study.
    Yamaguchi T; Takashima A; Nagashima K; Kumagai K; Yamada T; Terashima M; Yabusaki H; Nishikawa K; Tanabe K; Yunome G; Kawachi Y; Yamada T; Fukagawa T; Kinoshita T; Watanabe M; Ishiyama K; Inoue K; Boku N
    Gastric Cancer; 2023 Mar; 26(2):307-316. PubMed ID: 36695982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for cytology-positive gastric cancer.
    Endo S; Ikenaga M; Ohta K; Ueda M; Tsuda Y; Kato R; Itakura H; Matsuyama J; Nishikawa K; Yamada T
    Surg Today; 2019 Jan; 49(1):56-64. PubMed ID: 30167924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of perioperative staging laparoscopy for advanced gastric cancer.
    Ishigami S; Uenosono Y; Arigami T; Yanagita S; Okumura H; Uchikado Y; Kita Y; Kurahara H; Kijima Y; Nakajo A; Maemura K; Natsugoe S
    World J Surg Oncol; 2014 Nov; 12():350. PubMed ID: 25407392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of pre-operative peritoneal lavage examination in serosa-invading gastric cancer patients.
    Makino T; Fujiwara Y; Takiguchi S; Miyata H; Yamasaki M; Nakajima K; Nishida T; Mori M; Doki Y
    Surgery; 2010 Jul; 148(1):96-102. PubMed ID: 20096433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.